What transforms an avian influenza virus into one capable of causing devastating disease? At Options XIII, delegates will hear from Dr. Mathilde Richard, Associate Professor in the Department of Viroscience at Erasmus MC, Netherlands, whose research is helping answer this critical question.
Dr. Mathilde Richard on HPAI virus emergence
A biochemical engineer and molecular virologist, Dr. Richard began her career investigating antiviral resistance in influenza A viruses before turning her attention to the factors that drive the emergence of pandemic influenza strains. Since establishing her research group in 2018, she has focused on understanding how highly pathogenic avian influenza viruses (HPAIV) emerge, how they cause disease, and how new vaccination strategies can better protect against evolving viruses.
Her presentation, “Mechanisms of highly pathogenic avian influenza virus genesis”, will examine one of the key molecular changes that allows avian influenza viruses to become highly pathogenic. As HPAI viruses continue to spread globally and pose an ongoing threat to both animal and human health, understanding these mechanisms is essential for improving surveillance, preparedness, and future vaccine design.
Join Dr. Richard at Options XIII to gain insight into the cutting edge research shaping our understanding of one of influenza’s greatest challenges.
Further reading
